NL8720186A - Anti-verkoudheidspakket, anti-verkoudheidspreparaat en gebruik ervan. - Google Patents
Anti-verkoudheidspakket, anti-verkoudheidspreparaat en gebruik ervan. Download PDFInfo
- Publication number
- NL8720186A NL8720186A NL8720186A NL8720186A NL8720186A NL 8720186 A NL8720186 A NL 8720186A NL 8720186 A NL8720186 A NL 8720186A NL 8720186 A NL8720186 A NL 8720186A NL 8720186 A NL8720186 A NL 8720186A
- Authority
- NL
- Netherlands
- Prior art keywords
- cold
- ascorbate
- dexpanthenol
- water
- soluble
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 38
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 78
- 235000010323 ascorbic acid Nutrition 0.000 claims description 37
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 36
- 239000011668 ascorbic acid Substances 0.000 claims description 36
- 235000004866 D-panthenol Nutrition 0.000 claims description 34
- 239000011703 D-panthenol Substances 0.000 claims description 34
- 229960003949 dexpanthenol Drugs 0.000 claims description 34
- 229940072107 ascorbate Drugs 0.000 claims description 32
- 239000000203 mixture Substances 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 23
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 15
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 229960005055 sodium ascorbate Drugs 0.000 claims description 14
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical group [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 14
- 238000011282 treatment Methods 0.000 claims description 14
- 201000009240 nasopharyngitis Diseases 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 7
- 239000000872 buffer Substances 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 241000124008 Mammalia Species 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 230000000699 topical effect Effects 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 2
- 238000011321 prophylaxis Methods 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims 4
- 206010027654 Allergic conditions Diseases 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 229940068196 placebo Drugs 0.000 description 9
- 239000000902 placebo Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 210000001331 nose Anatomy 0.000 description 7
- 239000006196 drop Substances 0.000 description 6
- 210000004400 mucous membrane Anatomy 0.000 description 6
- 239000011521 glass Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 229940100662 nasal drops Drugs 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 230000000069 prophylactic effect Effects 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 241000709661 Enterovirus Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000007923 nasal drop Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- -1 for example Chemical class 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- 239000000644 isotonic solution Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000033116 oxidation-reduction process Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 150000000994 L-ascorbates Chemical class 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000004260 Potassium ascorbate Substances 0.000 description 1
- 206010061494 Rhinovirus infection Diseases 0.000 description 1
- AHLYXGYSBJNLAA-UHFFFAOYSA-N [K].N#C[Fe](C#N)C#N Chemical compound [K].N#C[Fe](C#N)C#N AHLYXGYSBJNLAA-UHFFFAOYSA-N 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- QKWNIOMGXBERHJ-RXSVEWSESA-N azane;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one Chemical compound N.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QKWNIOMGXBERHJ-RXSVEWSESA-N 0.000 description 1
- 229940002010 banana extract Drugs 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 235000010376 calcium ascorbate Nutrition 0.000 description 1
- 229940047036 calcium ascorbate Drugs 0.000 description 1
- 239000011692 calcium ascorbate Substances 0.000 description 1
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 230000000332 continued effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- SNPLKNRPJHDVJA-UHFFFAOYSA-N dl-panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000019275 potassium ascorbate Nutrition 0.000 description 1
- 229940017794 potassium ascorbate Drugs 0.000 description 1
- CONVKSGEGAVTMB-RXSVEWSESA-M potassium-L-ascorbate Chemical compound [K+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] CONVKSGEGAVTMB-RXSVEWSESA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000011885 synergistic combination Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229940056904 zinc ascorbate Drugs 0.000 description 1
- WWRJFSIRMWUMAE-ZZMNMWMASA-L zinc;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-olate Chemical compound [Zn+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] WWRJFSIRMWUMAE-ZZMNMWMASA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO861585A NO161779C (no) | 1986-04-22 | 1986-04-22 | Fremgangsmaate for fremstilling av et antiforkjoelsespreparat. |
| NO861585 | 1986-04-22 | ||
| EP8700203 | 1987-04-15 | ||
| PCT/EP1987/000203 WO1987006465A1 (en) | 1986-04-22 | 1987-04-15 | Anti-cold kit, anti-cold preparation and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8720186A true NL8720186A (nl) | 1988-03-01 |
Family
ID=19888883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8720186A NL8720186A (nl) | 1986-04-22 | 1987-04-15 | Anti-verkoudheidspakket, anti-verkoudheidspreparaat en gebruik ervan. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0264410A1 (ja) |
| JP (1) | JPS63503068A (ja) |
| KR (1) | KR880701100A (ja) |
| AU (1) | AU7239987A (ja) |
| DE (1) | DE3790208T1 (ja) |
| DK (1) | DK674587A (ja) |
| FI (1) | FI875624A (ja) |
| GB (1) | GB2198946A (ja) |
| IL (1) | IL82281A0 (ja) |
| NL (1) | NL8720186A (ja) |
| NO (1) | NO161779C (ja) |
| SE (1) | SE8705060D0 (ja) |
| WO (1) | WO1987006465A1 (ja) |
| ZA (1) | ZA872824B (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU662505B2 (en) * | 1990-12-06 | 1995-09-07 | Leslie Binshyang Soong | Substance that can stop bleeding in surgical, medical and dental uses/substance powder 001 that can stop bleeding during surgery, after surgery, medicine, dentistry or any bleeding due to any causes |
| US5935584A (en) * | 1994-01-13 | 1999-08-10 | Elizabeth Arden Company | Vitamin C delivery system |
| EP0729746A1 (en) * | 1995-02-28 | 1996-09-04 | Unilever Plc | Vitamin C delivery system |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4940728A (en) * | 1985-05-17 | 1990-07-10 | Postley John E | Treatment for sino-nasal congestion |
-
1986
- 1986-04-22 NO NO861585A patent/NO161779C/no unknown
-
1987
- 1987-04-15 KR KR1019870701206A patent/KR880701100A/ko not_active Application Discontinuation
- 1987-04-15 GB GB08729227A patent/GB2198946A/en active Pending
- 1987-04-15 EP EP87902498A patent/EP0264410A1/en not_active Withdrawn
- 1987-04-15 WO PCT/EP1987/000203 patent/WO1987006465A1/en not_active Application Discontinuation
- 1987-04-15 JP JP62502527A patent/JPS63503068A/ja active Pending
- 1987-04-15 NL NL8720186A patent/NL8720186A/nl unknown
- 1987-04-15 AU AU72399/87A patent/AU7239987A/en not_active Abandoned
- 1987-04-15 DE DE19873790208 patent/DE3790208T1/de not_active Withdrawn
- 1987-04-22 ZA ZA872824A patent/ZA872824B/xx unknown
- 1987-04-22 IL IL82281A patent/IL82281A0/xx unknown
- 1987-12-18 SE SE8705060A patent/SE8705060D0/xx not_active Application Discontinuation
- 1987-12-21 FI FI875624A patent/FI875624A/fi not_active Application Discontinuation
- 1987-12-21 DK DK674587A patent/DK674587A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK674587D0 (da) | 1987-12-21 |
| NO161779B (no) | 1989-06-19 |
| IL82281A0 (en) | 1987-12-31 |
| EP0264410A1 (en) | 1988-04-27 |
| SE8705060L (sv) | 1987-12-18 |
| GB8729227D0 (en) | 1988-02-17 |
| DE3790208T1 (ja) | 1988-04-21 |
| NO861585L (no) | 1987-10-23 |
| GB2198946A (en) | 1988-06-29 |
| ZA872824B (en) | 1987-11-25 |
| DK674587A (da) | 1987-12-21 |
| WO1987006465A1 (en) | 1987-11-05 |
| FI875624A0 (fi) | 1987-12-21 |
| NO161779C (no) | 1989-10-04 |
| JPS63503068A (ja) | 1988-11-10 |
| SE8705060D0 (sv) | 1987-12-18 |
| KR880701100A (ko) | 1988-07-25 |
| AU7239987A (en) | 1987-11-24 |
| FI875624A (fi) | 1987-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2344911T3 (es) | Composicion novedosa para tratar la xerostomia. | |
| US10751343B2 (en) | Nasal compositions stimulating ciliary activity | |
| JP2016517445A (ja) | ポリフェノール／フラボノイド組成物および口腔衛生製品を調合する方法 | |
| ES2207191T3 (es) | Composiciones orales antimicrobianas y antiolor. | |
| MXPA97002456A (en) | Liquid antiacidal compositions containing calcium carbonate and possibly simeticone as active compounds and monobasic potassium phosphate and potassium bicarbonate as regula | |
| McGrady et al. | Why fluoride? | |
| US20080112902A1 (en) | Protective Dental Balm and Method | |
| WO2022160718A1 (zh) | 一种增强氟活性的抗敏感牙膏 | |
| US20060239938A1 (en) | Dental balm and method of prevention of damage to teeth | |
| CN113081900A (zh) | 一种漱口液及其制备方法和应用 | |
| NL8720186A (nl) | Anti-verkoudheidspakket, anti-verkoudheidspreparaat en gebruik ervan. | |
| WO2021013283A1 (de) | Mundhygienemittel enthaltend koffein und l-lysin als bitterblocker | |
| EP3043783A1 (fr) | Complexe lubrifiant pour la bouche | |
| JP2012188377A (ja) | 口腔用組成物 | |
| US20220023426A1 (en) | Oral mucosal carrier and protectant | |
| EP2399568A1 (en) | Teeth whitening composition and method | |
| WO2015036533A1 (fr) | Systeme lubrifiant a action prolongee pour la bouche | |
| Kaur et al. | The immediate Term effect of chewing commercially available Meswak (Salvadora persica) on levels of Calcium, Chloride, Phosphate and Thiocyanate in whole saliva | |
| CA2555095A1 (en) | Dental balm and method of prevention of damage to teeth | |
| US20140345648A1 (en) | Oral Healthcare, Products and Methods Therefor | |
| Muhler et al. | Fluorine storage in rats receiving different fluorides in the drinking water at varying pH | |
| KR20050058069A (ko) | 소프트 비드를 함유하는 치약 조성물 | |
| Balaji et al. | Chewing gum practice among dental students. | |
| Bayou | Role Of Fluoride In Dental Health | |
| Yazıcıoğlu et al. | Ingredients in commercially available mouthwashes |